| 中國醫藥大學 |
2015-06-29 |
Lapatinibenhances migration ability of triple-negative breast cancer cells through induction of Raf-1/MAPK-dependent interleukin-6 expression by downergulationof microRNA-7
|
蕭宇君(Yu-Chun Hsiao);陳韻如(Yun-Ju Chen);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2015-06-29 |
HBx sensitizes HCC cell lines to lapatinib by up-regulating ErbB3
|
陳貞妤(Jhen Yu Chen);陳韻如(Yun-Ju Chen);陳雯淑(Wen Shu Chen);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2015-05-03 |
HER2 upregulates PD-L1 expression through PI3K-Akt pathway
|
施志諭(Chih-Yu Shih);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2015-03-22 |
Pim kinase inhibitors possess anticancer properties through downregulation of EGFR family in HER2-positive cancer cells
|
王于菲(Yu-Fei Wang);王文玲(Wen-Ling Wang);黃偉謙(Wei-Chien Huang)*;黃偉謙(Wei-Chien Huang) |
| 亞洲大學 |
2015 |
MiRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
|
Wen-Shu Chen(Wen-Shu Chen); Chia-Jui Yen(Chia-Jui Yen); Yun-Ju Chen(Yun-Ju Chen); Jhen-Yu Chen(Jhen-Yu Chen); Li-Yun Wang(Li-Yun Wang); Shu-Jun Chiu(Shu-Jun Chiu); Wen-Ling Shi; Chien-Yi Ho; , (Tzu-Tang Wei,); Pei-Hsuan Ch(Pei-Hsuan Chien); 洪明奇; Ching-Chow C(Ching-Chow Chen); 黃偉謙(Wei-Chien Huang)* |
| 中國醫藥大學 |
2014-12-31 |
HER2調控 EZH2 表現於乳癌發展之角色探討
|
黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2014-10-19 |
MicroRNA-221/222 confers lapatinib resistance through targeting p27kip1 expression.
|
陳貞妤(Chen Jhen-Yu);陳韻如(Chen Yun-Ju);楊逸翔(Yan Yi-Shian);葉名焮(Ming-Hsin, Alex, Yeh);黃偉謙(Wei-Chien Huang)* |
| 中國醫藥大學 |
2014-07-31 |
LKB1/AMPK 能量調節路徑於 EGFR TKI 抗腫瘤作用之角色探討
|
黃偉謙(Wei-Chien Huang);陳韻如 |
| 中國醫藥大學 |
2014-07-31 |
EGFR訊息傳遞與癌細胞代謝調控之交互作用探討－葡萄糖吸收與內質網壓力影響EGFR TKIs 抗癌效果之角色探討(1/3)
|
黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2014-06 |
Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma
|
(Wu CS);(Lee TY);鄒瑞煌(Ruey-Hwang Chou);(Yen CJ);黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)* |
| 中國醫藥大學 |
2014-05-27 |
Lapatinib induces IL-6 expression via MAPK pathway in triple-negative breast cancer cells
|
蕭宇君(Hsiao Yu-Chun);陳孟良(Mong-Liang Chen);陳韻如(Chen Yun-Ju);湯智昕(Tang Chih-Hsin);黃偉謙(Wei-Chien Huang)* |
| 中國醫藥大學 |
2014-05-27 |
ERK-mediated HER2 Thr701 phosphorylation negatively regulates HER2/AKT axis activation through reducing EGFR/HER2 dimerization in a clathrin-dependent manner
|
魏雅鈴(Ya-Ling Wei);陳雯淑(Chen Wen-Shu);葉名焮(Ming-Hsin, Alex, Yeh);陳韻如(Chen Yun-Ju);黃偉謙(Wei-Chien Huang)* |
| 中國醫藥大學 |
2014-05-27 |
Suppression of Maspin by IKKα-dependent MicroRNAs Confer HBx-mediated Hepatocellular Cancer Progression
|
陳雯淑(Chen Wen-Shu);顏家瑞(Yen Chia-Jui);陳韻如(Chen Yun-Ju);陳貞妤(Chen Jhen-Yu);劉淑惠;魏子堂(Wei Tzu-Tang);洪明奇(Mien-Chie Hung);陳青周(Chen Ching-Chow);黃偉謙(Wei-Chien Huang)* |
| 中國醫藥大學 |
2014-05-27 |
TrichostatinA Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells
|
涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);夏德椿(Te-Chun Hsia);許閔翔(Hsu Min-Hsiang);魏雅鈴(Ya-Ling Wei);游孟潔(Yu Meng-Chieh);陳雯淑(Chen Wen-Shu);許克瑋(Hsu Ke-Wei);葉名焮(Ming-Hsin, Alex, Yeh);劉良智(Liu, Liang-Chih);陳韻如(Chen Yun-Ju);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2014-04 |
Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2–induced Globo H expression
|
吳承修;(Yen CJ);鄒瑞煌(Ruey-Hwang Chou);陳佳妮;黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)* |
| 中國醫藥大學 |
2014-03-16 |
Proteasome inhibitors overcome lapatinib resistance by downregulation of HER family
|
黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2014-02-28 |
利用Lapatinib脫靶效應增強HDAC抑制劑治療三陰性乳癌效果之探討
|
黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2014-02-28 |
4D PETCT評估呼吸運動與腫瘤位置對胸腔腫瘤PET造影的影響
|
黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2014-01-31 |
跨國頂尖癌症研究中心(2/5)
|
陳志毅(Chih-Yi Chen);吳永昌(Yang-Chang Wu);蔡輔仁(Fuu-Jen Tsai);陳孟良(Mong-Liang Chen);黃偉謙(Wei-Chien Huang);張為超(Wei-Chao Chang);邱昌芳(Chang-Fang Chiu) |
| 中國醫藥大學 |
2014-01 |
Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells
|
涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);夏德椿(Te-Chun Hsia);(Min-Hsiang Hsu);魏雅鈴(Ya-Ling Wei);(Meng-Chie Yu);葉名焮(Ming-Hsin, Alex, Yeh);劉良智(Liu, Liang-Chih);(Yun-Ju Chen);(Wen-Shu Chen);(Ke-Wei Hsu);黃偉謙(Wei-Chien Huang)* |
| 中國醫藥大學 |
2014-01 |
Hepatitis B virus X up-regulates HuR protein level to stabilize HER2 expression in hepatocellular carcinoma cells
|
(Chao-Ming Hung);黃偉謙(Wei-Chien Huang);(Hsiao-Lin Pan);(Pei-Hsuan Chien);(Chih-Wen Lin);(Lei-Chin Chen);(Yu-Fong Chien);(Ching-Chiao Lin);(Kar-Hee Leow);(Wen-Shu Chen);(Jhen-Yu Chen);(Pao-Sheng Hou);何建宜(Chien-Yi Ho);(Yun-Ju Chen)* |
| 中國醫藥大學 |
2013-12-31 |
Lapatinib 脫靶效應增強HDAC抑制劑對三陰性乳癌治療效果之探討
|
葉名焮(Ming-Hsin, Alex, Yeh);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2013-12-08 |
EGFR突變型的過度表現經由活化TENASCIN-C增加頭頸部鱗狀上皮癌細胞的侵犯力與降低癌瘲病人存活率
|
蔡銘修(Ming-Hsui Tsai);詹佳穎(Chia-Ing Jan);韓鴻志(Horng-Jyh Harn);黃偉謙(Wei-Chien Huang);洪明奇(Mien-Chie Hung) |
| 中國醫藥大學 |
2013-12 |
BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
|
黃偉謙(Wei-Chien Huang);(Yi-Ling Hsieh);(Chao-Ming Hung);(Pei-Hsuan Chien);(Yu-Fong Chien);(Lei-Chin Chen);涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);(Sheng-Chieh Hsu);(Yueh-Ming Lin);(Yun- Ju Chen)* |
| 中國醫藥大學 |
2013-11 |
Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
|
(Yun-Ju Chen);葉名焮(Ming-Hsin, Alex, Yeh);游孟潔(Meng-Chieh Yu);魏雅鈴(Ya-Ling Wei);(Wen-Shu Chen);(Jhen-Yu Chen);(Chih-Yu Shih);涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);夏德椿(Te-Chun Hsia);(Pei-Hsuan Chien);(Shu-Hui Liu);余永倫(Yung-Luen Yu);黃偉謙(Wei-Chien Huang)* |
